195 related articles for article (PubMed ID: 9143054)
1. Brachytherapy in primary ocular tumors.
Freire JE; De Potter P; Brady LW; Longton WA
Semin Surg Oncol; 1997; 13(3):167-76. PubMed ID: 9143054
[TBL] [Abstract][Full Text] [Related]
2. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
[TBL] [Abstract][Full Text] [Related]
3. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
[TBL] [Abstract][Full Text] [Related]
4. Ocular complications following I-125 brachytherapy for choroidal melanoma.
Wen JC; Oliver SC; McCannel TA
Eye (Lond); 2009 Jun; 23(6):1254-68. PubMed ID: 19265865
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.
Dean MK; Studenski MT; Paez-Escamilla MA; Walter SD; Kwon D; Markoe AM; Harbour JW; Samuels SE
Brachytherapy; 2019; 18(3):404-410. PubMed ID: 30797699
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
7. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
[TBL] [Abstract][Full Text] [Related]
9. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
10. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159
[TBL] [Abstract][Full Text] [Related]
11. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM;
Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893
[TBL] [Abstract][Full Text] [Related]
12. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
[TBL] [Abstract][Full Text] [Related]
13. Golden Jubilee Lecture. Randomised clinical trials of choroidal melanoma treatment.
Straatsma BR
Indian J Ophthalmol; 2003 Mar; 51(1):17-23. PubMed ID: 12701858
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
[TBL] [Abstract][Full Text] [Related]
15. Collaborative ocular melanoma study randomized trial of I-125 brachytherapy.
Hawkins BS
Clin Trials; 2011 Oct; 8(5):661-73. PubMed ID: 22013172
[TBL] [Abstract][Full Text] [Related]
16. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
Lee YC; Lin SC; Kim Y
Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
[TBL] [Abstract][Full Text] [Related]
17. Episcleral brachytherapy for uveal melanoma: analysis of 136 cases.
García-Álvarez C; Saornil MA; López-Lara F; Almaraz A; Muñoz MF; Frutos-Baraja J; Muiños Y
Clin Transl Oncol; 2012 May; 14(5):350-5. PubMed ID: 22551540
[TBL] [Abstract][Full Text] [Related]
18. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
19. External beam radiation for retinoblastoma: results, patterns of failure, and a proposal for treatment guidelines.
Hernandez JC; Brady LW; Shields JA; Shields CL; DePotter P; Karlsson UL; Markoe AM; Amendola BE; Singh A
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):125-32. PubMed ID: 8641908
[TBL] [Abstract][Full Text] [Related]
20. Local control and visual acuity following treatment of medium-sized ocular melanoma using a contact eye plaque: a single surgeon experience.
Karlovits B; Trombetta MG; Verstraeten T; Johnson M; Wong M; Karlovits S
Brachytherapy; 2011; 10(3):228-31. PubMed ID: 20932809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
